Moderna ( MRNA ) Reports Q4 Loss, Tops Revenue Estimates
Moderna (MRNA) delivered earnings and revenue surprises of 7.06% and 1.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
https://www.zacks.com/stock/news/2416004/moderna-mrna-reports-q4-loss-tops-revenue-estimates